Product Information
OLMESARTAN MEDOXOMIL 20 MG TAB is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.0810 per EA under NDC 50228034010. Its NADAC has been published 388 times since Mar 20, 2019.
FDA first approved this application on Jun 29, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
ScieGen Pharmaceuticals, Inc.NDC
50228034010
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA208130FDA Approved
6/29/2018
TE Code
AB
On Market Since
6/29/2018
Pharmacological Classes
Price Statistics
The NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has been published 388 times since Mar 20, 2019, and over the history we have for it it has declined 32.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0810 per EA |
|---|---|
| All-time high | $0.1402 (Feb 10, 2021) |
| All-time low | $0.0705 (Nov 20, 2024) |
| 52-week high | $0.0825 |
| 52-week low | $0.0732 |
| Median price | $0.0935 |
| Average price | $0.1001 |
| Largest weekly change | +25.6% (Jan 20, 2021) |
| Weeks tracked | 388 |
| Tracking since | Mar 20, 2019 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OLMESARTAN MEDOXOMIL 20 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN MEDOXOMIL 20 MG TAB, manufactured by ScieGen Pharmaceuticals, Inc., is $0.0810 per EA (NDC 50228034010), effective Aug 19, 2026.
How has the price of OLMESARTAN MEDOXOMIL 20 MG TAB changed over time?
Over the history we have for it, the NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has declined 32.6%. It has been tracked across 388 weekly CMS publications since Mar 20, 2019.
What are the highest and lowest recorded NADAC prices for OLMESARTAN MEDOXOMIL 20 MG TAB?
Since Mar 20, 2019, the NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has ranged from a low of $0.0705 (Nov 20, 2024) to a high of $0.1402 (Feb 10, 2021), with a median of $0.0935 per EA.
Are there cheaper alternatives to OLMESARTAN MEDOXOMIL 20 MG TAB?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OLMESARTAN MEDOXOMIL 20 MG TAB, is $0.0780 per EA — about 4% below OLMESARTAN MEDOXOMIL 20 MG TAB.
Who manufactures OLMESARTAN MEDOXOMIL 20 MG TAB?
OLMESARTAN MEDOXOMIL 20 MG TAB (NDC 50228034010) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.